Dr. Matthew Prime
Roche Diagnostics Information Solutions
Dr. Matt Prime is the Global Medical Director for Roche Diagnostics Information Solutions (DIS) based in Basel, Switzerland. Dr. Prime graduated from University College London in 2005 with a medical degree and a bachelor’s
degree in tumor biology. He spent 12 years in clinical practice in the United Kingdom working as a trauma & orthopedic surgeon. In 2013 he co-developed PathPoint TM – a patient care coordination system - to help frontline
trauma surgeons better organize the care of patients. This solution has now been widely implemented across the NHS and in 2017, in recognition of his work in digital healthcare he became an NHS clinical entrepreneurship
In 2014 he took up an academic appointment at Imperial College London, within the Institute of Global Health Innovation (IGHI) led by Professor the Lord Darzi of Denham, former Under-Secretary of State at the UK Department of Health. His PhD focused on the enablers and barriers to innovation diffusion in the healthcare sector, with specific reference to innovation originating in low or middle-income countries. Between 2014-17 he was the clinical advisor to the HELIX Center for Design in Healthcare, a design studio in the heart of St Mary’s
Hospital in London, applying design-thinking to develop patient-centered digital healthcare solutions.
Personalized healthcare: Leveraging data to improve patient care through clinical decision support in oncology
Roche, known for its biopharmaceuticals and in-vitro diagnostics solutions has entered the field of Clinical Decision Support by building a portfolio of software products.
Learn how the NAVIFY ® Decision Support portfolio leverages excellence in clinical workflow, advanced analytics and innovative strategic partnerships to bring together diagnostic, real-world data to deliver personalized healthcare.
EVEN MORE SEMINARS
Kate Casey The Leeds Gamma Knife Centre
ICON LEKSELL GAMMA KNIFE STEREOTACTIC RADIOSURGERY
Bertil RR Persson Scandinavian ChemoTech AB. Sweden
Dynamic-ElectroEnhanced Chemotherapy brings relief to patients with large tumour burden
DR Zayad Ratansi o3 Health Ltd
Hyperbarics within Oncology
Professor Hisham Mehanna InHANSE, Institute of Cancer and Genomic Sciences, University of Birmingham
Clinical trials that change patient care and the lessons learnt
James Flanagan Imperial College London
Epigenetic biomarkers for platinum response in ovarian cancer